160 related articles for article (PubMed ID: 30903272)
21. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
22. Diverse glandular pathologies coexist with high-grade squamous intraepithelial lesion in cyto-histological review of atypical glandular cells on ThinPrep specimens.
Kumar N; Bongiovanni M; Molliet MJ; Pelte MF; Egger JF; Pache JC
Cytopathology; 2009 Dec; 20(6):351-8. PubMed ID: 18522633
[TBL] [Abstract][Full Text] [Related]
23. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium.
Toda T; Sadi AM; Egawa H; Atari E; Qureshi B; Nagai Y
Histopathology; 1998 Mar; 32(3):257-63. PubMed ID: 9568512
[TBL] [Abstract][Full Text] [Related]
24. Endocervical adenocarcinoma in situ presenting in fundal endometrial polyp: the mother of all skip lesions.
Roberts JM; Cornall AM; Lamaro V; Tabrizi SN; Russell P
Int J Gynecol Pathol; 2015 May; 34(3):228-31. PubMed ID: 25844546
[TBL] [Abstract][Full Text] [Related]
25. Atypical endocervical glandular cells: accuracy of cytologic diagnosis.
Lee KR; Manna EA; St John T
Diagn Cytopathol; 1995 Oct; 13(3):202-8. PubMed ID: 8575278
[TBL] [Abstract][Full Text] [Related]
26. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the antigenicity of amylase in cervical glandular atypia, adenocarcinoma in situ and invasive adenocarcinoma.
Griffin NR; Wells M; Fox H
Histopathology; 1989 Sep; 15(3):267-79. PubMed ID: 2478438
[TBL] [Abstract][Full Text] [Related]
28. Two cases of adenocarcinoma in situ arising in lobular endocervical glandular hyperplasia indicating localization of mucin on the cluster surface as an early cytological finding of malignant transformation.
Okuyama R; Hashimoto H; Miura T; Sugita M; Arai M; Tsunoda H; Sasajima Y; Horiuchi H
Diagn Cytopathol; 2017 Sep; 45(9):842-847. PubMed ID: 28449203
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesions.
El-Ghobashy AA; Shaaban AM; Innes J; Prime W; Herrington CS
Eur J Cancer; 2007 Sep; 43(13):2011-8. PubMed ID: 17693084
[TBL] [Abstract][Full Text] [Related]
30. Cervical glandular neoplasia referrals and the diagnosis of adenocarcinoma in situ: Correlating cytology, colposcopy findings, and clinical outcomes.
Nikolopoulos M; Athanasias P; Godfrey MAL; Nikolopoulos K; Maheshwari MK
Cytopathology; 2021 Nov; 32(6):751-757. PubMed ID: 34181788
[TBL] [Abstract][Full Text] [Related]
31. Early endocervical glandular neoplasia. II. Morphometric analysis of the cells.
Clark AH; Betsill WL
Acta Cytol; 1986; 30(2):127-34. PubMed ID: 3457504
[TBL] [Abstract][Full Text] [Related]
32. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist?
Goldstein NS; Ahmad E; Hussain M; Hankin RC; Perez-Reyes N
Am J Clin Pathol; 1998 Aug; 110(2):200-9. PubMed ID: 9704619
[TBL] [Abstract][Full Text] [Related]
33. [Precancerous lesions of the uterine cervix: morphology and molecular pathology].
Horn LC; Klostermann K
Pathologe; 2011 Nov; 32 Suppl 2():242-54. PubMed ID: 21909794
[TBL] [Abstract][Full Text] [Related]
34. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
Jaworski RC
Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
[TBL] [Abstract][Full Text] [Related]
35. Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Mikami Y; Minamiguchi S; Teramoto N; Nagura M; Haga H; Konishi I
Pathol Res Pract; 2013 Mar; 209(3):173-8. PubMed ID: 23391777
[TBL] [Abstract][Full Text] [Related]
36. The two faces of cervical adenocarcinoma in situ.
Smedts F; Ramaekers FC; Hopman AH
Int J Gynecol Pathol; 2010 Jul; 29(4):378-85. PubMed ID: 20567153
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
Asaka S; Nakajima T; Kugo K; Kashiwagi R; Yazaki N; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2020 Apr; 476(4):499-510. PubMed ID: 31932920
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
39. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears.
Novotny DB; Maygarden SJ; Johnson DE; Frable WJ
Acta Cytol; 1992; 36(1):1-10. PubMed ID: 1546503
[TBL] [Abstract][Full Text] [Related]
40. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions.
van Hoeven KH; Ramondetta L; Kovatich AJ; Bibbo M; Dunton CJ
Int J Gynecol Pathol; 1997 Jan; 16(1):15-21. PubMed ID: 8986527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
